Analyst Consensus ?
ConsensusHold40 ratings
Bullish1127.5%
Neutral2357.5%
Bearish615.0%
1 unmapped firm rating excluded from the percentages.
Best Buy Co., Inc. · BBY · FY2024 Q4 · Calendar Q1 2024
Best Buy leans on memberships and services as sales outlook stays soft
Best Buy's earnings support a mixed view: membership, services, health, and advertising provide resilience, but the maintained flat-to-down sales outlook shows that demand recovery is not yet established.
Reported Before market openNYSEConsumer Cyclical
$20.95B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$2.72
Consensus $2.52
EPS surprise
+7.9%
Reported versus consensus
Reported revenue
$14.65B
Consensus $14.56B
Revenue surprise
+0.6%
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
+1.5%
Event window
SPY move
+0.4%
Same window
Abnormal move
+1.1%
Stock minus SPY
Volume
3.3×
Versus trailing sessions
Subsequent drift
+1.4%
Up to 20 sessions
BBYSPY benchmark
Ask FN2 about BBY FY2024 Q4
Transcript, numbers and history already loaded
Why did BBY rise 1.5% after beating EPS estimates in FY2024 Q4?What changed in BBY's guidance and outlook in FY2024 Q4?Give me the bull and bear case for BBY after FY2024 Q4 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The current analysis shifts emphasis toward a 7 million paid-membership base, broader service and health opportunities, AI personalization, store refreshes, and a Canada Express rollout; the sales outlook remains cautious.
Guidance delta
Maintained: FY25 sales outlook was flat to down 3%, with capital expenditures near the prior-year level.
Key takeaways
- Profitability exceeded expectations despite a comparable-sales decline, supported by membership fees and services.
- Paid membership reached 7 million, and management highlighted Best Buy Health, advertising, and store refreshes as growth avenues.
- The FY25 outlook remains flat to down 3% for sales, while AI personalization and customer-experience initiatives remain priorities.
Management priorities
- Refresh the store fleet and improve merchandising and customer experience.
- Expand AI-driven personalization and operational applications.
- Scale Best Buy Health, advertising, and the Best Buy Express rollout in Canada.
Follow BBY with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$99.87Current
$60Low
$91.31Average
$147High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 25, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Evercore ISI Group | In Line | In Line | Maintain | Oct 20, 2026 |
| DA Davidson | Neutral | Buy | Downgrade | Sep 8, 2026 |
| UBS | Neutral | Neutral | Maintain | Aug 28, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Aug 28, 2026 |
| Guggenheim | Buy | Buy | Maintain | Aug 28, 2026 |
| Goldman Sachs | Sell | Sell | Maintain | Aug 28, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Aug 28, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Aug 20, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Aug 13, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Aug 11, 2026 |
| Truist Securities | Buy | Hold | Upgrade | Aug 11, 2026 |
| Jefferies | Hold | Buy | Downgrade | Aug 5, 2026 |
| Loop Capital | Hold | Buy | Downgrade | Jul 13, 2026 |
| Wedbush | Neutral | Neutral | Maintain | May 29, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | May 29, 2026 |
| BNP Paribas | Neutral | Neutral | Maintain | Mar 4, 2026 |
| Telsey Advisory Group | Outperform | Outperform | Maintain | Feb 24, 2026 |
| Argus Research | Hold | Hold | Maintain | Sep 16, 2025 |
| B of A Securities | Underperform | Underperform | Maintain | Aug 29, 2025 |
| Keybanc | Sector Weight | Maintain | Mar 5, 2025 | |
| Credit Suisse | Neutral | Neutral | Maintain | May 26, 2023 |
| Exane BNP Paribas | Neutral | Outperform | Downgrade | Jan 12, 2023 |
| R5 Capital | Sell | Buy | Downgrade | Jul 28, 2022 |
| Raymond James | Market Perform | Outperform | Downgrade | Mar 4, 2022 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Feb 26, 2021 |
| Oppenheimer | Perform | Outperform | Downgrade | Oct 23, 2020 |
| Nomura Instinet | Neutral | Neutral | Maintain | May 22, 2020 |
| Nomura | Neutral | Neutral | Maintain | May 22, 2020 |
| CFRA | Buy | Buy | Maintain | May 21, 2020 |
| PiperJaffray | Overweight | Overweight | Maintain | Nov 27, 2019 |
| Bank of America | Underperform | Neutral | Downgrade | Dec 17, 2018 |
| Deutsche Bank | Hold | Hold | Maintain | Aug 29, 2018 |
| B. Riley FBR | Buy | Neutral | Upgrade | May 5, 2018 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Aug 24, 2016 |
| Stifel Nicolaus | Buy | Buy | Maintain | Nov 17, 2014 |
| Stifel | Buy | Buy | Maintain | Nov 17, 2014 |
| B. Riley Securities | Buy | Neutral | Upgrade | Aug 20, 2013 |
| Standpoint Research | Hold | Buy | Downgrade | Mar 5, 2013 |
| BB&T Capital | Buy | Hold | Upgrade | Jan 28, 2013 |
| Zacks Investment Research | Underperform | Neutral | Downgrade | Aug 24, 2012 |
| Bank oferica | Underperform | Underperform | Maintain | May 23, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $99.87. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Evercore ISI | Analyst unavailable | $95 | $91.13 | -4.9% | Oct 20, 2026 |
| D.A. Davidson | Analyst unavailable | $95 | $82.77 | -4.9% | Aug 28, 2026 |
| Morgan Stanley | Simeon Gutman | $90 | $83.56 | -9.9% | Aug 28, 2026 |
| UBS | Analyst unavailable | $90 | $83.56 | -9.9% | Aug 28, 2026 |
| Guggenheim | Analyst unavailable | $95 | $83.56 | -4.9% | Aug 28, 2026 |
| Goldman Sachs | Analyst unavailable | $71 | $83.56 | -28.9% | Aug 28, 2026 |
| Barclays | Analyst unavailable | $85 | $83.56 | -14.9% | Aug 28, 2026 |
| Truist Financial | Scot Ciccarelli | $100 | $83.56 | +0.1% | Aug 27, 2026 |
| Piper Sandler | Analyst unavailable | $85 | $89.21 | -14.9% | Aug 20, 2026 |
| Truist Financial | Analyst unavailable | $95 | $82.43 | -4.9% | Aug 11, 2026 |
| Jefferies | Analyst unavailable | $85 | $86.35 | -14.9% | Aug 5, 2026 |
| Loop Capital Markets | Analyst unavailable | $82 | $82.8 | -17.9% | Jul 13, 2026 |
| Telsey Advisory | Jospeh Feldman | $90 | $74.74 | -9.9% | May 29, 2026 |
| UBS | Michael Lasser | $86 | $74.74 | -13.9% | May 29, 2026 |
| Piper Sandler | Analyst unavailable | $77 | $76.21 | -22.9% | May 28, 2026 |
| Jefferies | Analyst unavailable | $89 | $76.24 | -10.9% | May 28, 2026 |
| UBS | Michael Lasser | $85 | $62.68 | -14.9% | May 26, 2026 |
| Wells Fargo | Analyst unavailable | $60 | $55.52 | -39.9% | May 14, 2026 |
| Evercore ISI | Analyst unavailable | $65 | $60.85 | -34.9% | Apr 14, 2026 |
| D.A. Davidson | Michael Baker | $78 | $66.06 | -21.9% | Mar 5, 2026 |
| Evercore ISI | Greg Melich | $75 | $67.6 | -24.9% | Mar 4, 2026 |
| Piper Sandler | Peter Keith | $68 | $67.71 | -31.9% | Mar 4, 2026 |
| Truist Financial | Scot Ciccarelli | $66 | $65.95 | -33.9% | Mar 3, 2026 |
| Piper Sandler | Analyst unavailable | $71 | $64.48 | -28.9% | Feb 23, 2026 |
| Wells Fargo | Analyst unavailable | $70 | $66.1 | -29.9% | Feb 18, 2026 |
| Evercore ISI | Analyst unavailable | $70 | $65.9 | -29.9% | Feb 3, 2026 |
| Truist Financial | Scot Ciccarelli | $73 | $68.14 | -26.9% | Jan 16, 2026 |
| Morgan Stanley | Simeon Gutman | $76 | $66.68 | -23.9% | Jan 15, 2026 |
| Barclays | Seth Sigman | $77 | $68.83 | -22.9% | Jan 8, 2026 |
| Truist Financial | Analyst unavailable | $77 | $72.6 | -22.9% | Dec 17, 2025 |
| Evercore ISI | Greg Melich | $80 | $72.56 | -19.9% | Dec 9, 2025 |
| Truist Financial | Analyst unavailable | $84 | $81.05 | -15.9% | Nov 26, 2025 |
| Morgan Stanley | Simeon Gutman | $82 | $81.24 | -17.9% | Nov 26, 2025 |
| UBS | Michael Lasser | $96 | $79.66 | -3.9% | Nov 26, 2025 |
| Barclays | Seth Sigman | $81 | $79.62 | -18.9% | Nov 25, 2025 |
| Jefferies | Jonathan Matuszewski | $95 | $76.77 | -4.9% | Oct 8, 2025 |
| Truist Financial | Analyst unavailable | $72 | $73.64 | -27.9% | Aug 29, 2025 |
| Wells Fargo | Analyst unavailable | $75 | $72.66 | -24.9% | Aug 29, 2025 |
| Piper Sandler | Peter Keith | $75 | $70.95 | -24.9% | Jul 14, 2025 |
| Loop Capital Markets | Analyst unavailable | $90 | $78.6 | -9.9% | Mar 6, 2025 |
| Telsey Advisory | Analyst unavailable | $100 | $75.53 | +0.1% | Mar 5, 2025 |
| UBS | Analyst unavailable | $105 | $75.53 | +5.1% | Mar 5, 2025 |
| Guggenheim | Analyst unavailable | $90 | $75.53 | -9.9% | Mar 5, 2025 |
| Truist Financial | Analyst unavailable | $81 | $75.53 | -18.9% | Mar 5, 2025 |
| Wells Fargo | Analyst unavailable | $85 | $75.53 | -14.9% | Mar 5, 2025 |
| Morgan Stanley | Analyst unavailable | $85 | $75.53 | -14.9% | Mar 5, 2025 |
| Guggenheim | Steven Forbes | $105 | $87.8 | +5.1% | Nov 29, 2024 |
| Melius Research | Karen Short | $100 | $97.05 | +0.1% | Sep 23, 2024 |
| Wedbush | Seth Basham | $95 | $100 | -4.9% | Aug 30, 2024 |
| Loop Capital Markets | Anthony Chukumba | $110 | $100 | +10.1% | Aug 30, 2024 |
| Evercore ISI | Greg Melich | $94 | $100.18 | -5.9% | Aug 30, 2024 |
| Piper Sandler | Peter Keith | $114 | $100.18 | +14.1% | Aug 30, 2024 |
| Barclays | Seth Sigman | $95 | $100.18 | -4.9% | Aug 30, 2024 |
| Jefferies | Jonathan Matuszewski | $116 | $99.64 | +16.2% | Aug 29, 2024 |
| Bank of America Securities | Elizabeth Suzuki | $70 | $88.91 | -29.9% | Aug 27, 2024 |
| UBS | Michael Lasser | $106 | $87.21 | +6.1% | Jun 17, 2024 |
| Loop Capital Markets | Anthony Chukumba | $100 | $88.82 | +0.1% | Jun 7, 2024 |
| Truist Financial | Scot Ciccarelli | $86 | $81.55 | -13.9% | May 31, 2024 |
| Evercore ISI | Greg Melich | $90 | $81.55 | -9.9% | May 31, 2024 |
| D.A. Davidson | Michael Baker | $90 | $81.55 | -9.9% | May 30, 2024 |
| Jefferies | Jonathan Matuszewski | $94 | $80.86 | -5.9% | Apr 8, 2024 |
| Telsey Advisory | Best Buy | $95 | $81.66 | -4.9% | Mar 22, 2024 |
| Telsey Advisory | Jospeh Feldman | $95 | $78.59 | -4.9% | Mar 20, 2024 |
| Truist Financial | Scot Ciccarelli | $87 | $78.4 | -12.9% | Mar 1, 2024 |
| Telsey Advisory | Joseph Feldman | $75 | $79.68 | -24.9% | Feb 29, 2024 |
| Wedbush | Seth Basham | $75 | $75.48 | -24.9% | Feb 8, 2024 |
| Wedbush | Seth Basham | $70 | $67.84 | -29.9% | Nov 22, 2023 |
| Goldman Sachs | Kate McShane | $85 | $70.09 | -14.9% | Oct 19, 2023 |
| Telsey Advisory | Joseph Feldman | $78 | $78.89 | -21.9% | Aug 21, 2023 |
| Telsey Advisory | Joseph Feldman | $81 | $70.63 | -18.9% | May 19, 2023 |
| Barclays | Analyst unavailable | $88 | $87.79 | -11.9% | Feb 8, 2023 |
| Credit Suisse | Analyst unavailable | $90 | $79.8 | -9.9% | Dec 20, 2022 |
| Goldman Sachs | Analyst unavailable | $83 | $81.81 | -16.9% | Dec 12, 2022 |
| Wedbush | Seth Basham | $85 | $81.55 | -14.9% | Nov 23, 2022 |
| Citigroup | Analyst unavailable | $72 | $80.99 | -27.9% | Nov 23, 2022 |
| Goldman Sachs | Analyst unavailable | $59 | $79.88 | -40.9% | Nov 23, 2022 |
| Telsey Advisory | Analyst unavailable | $88 | $79.88 | -11.9% | Nov 23, 2022 |
| J.P. Morgan | Analyst unavailable | $78 | $71.43 | -21.9% | Nov 18, 2022 |
| Guggenheim | Steven Forbes | $85 | $78.54 | -14.9% | Aug 8, 2022 |
| D.A. Davidson | Michael Baker | $110 | $83.99 | +10.1% | May 31, 2022 |
| Wedbush | Seth Basham | $80 | $73.47 | -19.9% | May 24, 2022 |
| Truist Financial | Scot Ciccarelli | $83 | $72.36 | -16.9% | May 21, 2022 |
| Telsey Advisory | Joe Feldman | $130 | $106.1 | +30.2% | Mar 4, 2022 |
| CFRA | Ken Leon | $100 | $109.16 | +0.1% | Mar 3, 2022 |
| Citigroup | Steven Zaccone | $87 | $95.78 | -12.9% | Feb 28, 2022 |
| Bank of America Securities | Elizabeth Lane Suzuki | $147 | $95.78 | +47.2% | Feb 28, 2022 |
| Morgan Stanley | Simeon Gutman | $110 | $97.76 | +10.1% | Jan 18, 2022 |
| Truist Financial | Scot Ciccarelli | $108 | $100.04 | +8.1% | Jan 17, 2022 |
| R5 Capital | Scott Mushkin | $140 | $103.03 | +40.2% | Dec 6, 2021 |
| D.A. Davidson | Michael Baker | $135 | $119.24 | +35.2% | Aug 25, 2021 |
| Barclays | Adrienne Yih | $100 | $119.24 | +0.1% | Aug 25, 2021 |
| Wedbush | Seth Basham | $130 | $119.24 | +30.2% | Aug 25, 2021 |
| Loop Capital Markets | Anthony Chukumba | $150 | $113.85 | +50.2% | Jun 7, 2021 |
Track every rating change on BBY the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationBest Buy Co., Inc. operates as a prominent technology retailer across the United States and Canada. Its business structure is segmented into Domestic and International operations. The company's extensive product selection includes a wide array of computing devices such as desktops, notebooks, and associated peripherals, alongside mobile phones (which generate commissions from network carriers), networking equipment, and tablets (including e-readers). Customers can also find smartwatches and various consumer electronics, encompassing digital imaging devices, health and fitness gadgets, home theater systems, portable audio solutions (like headphones and speakers), and smart home products. Beyond electronics, Best Buy also supplies household appliances such as dishwashers, laundry machines, ovens, refrigerators, blenders, coffee makers, and vacuum cleaners.…
Historical context
All BBY earningsConsumer Cyclical peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| DECK Deckers Outdoor Corporation | FY2027 Q2 · Calendar Q4 2026 | +13.4% | -0.2% | Deckers raises FY2027 outlook as HOKA and UGG drive growth |
| TSCO Tractor Supply Company | FY2026 Q3 · Calendar Q4 2026 | +5.3% | +6.2% | Tractor Supply Q3: Pet and Digital Momentum Supports Margin Plan |
| PHM PulteGroup, Inc. | FY2026 Q3 · Calendar Q4 2026 | -4.5% | +5.8% | PulteGroup Holds Guidance as Buyer Traffic Slows |
| PKG Packaging Corporation of America | FY2026 Q3 · Calendar Q4 2026 | +3.8% | +4.2% | PCA beats Q3 expectations as Greif synergies offset cost pressure |
Latest beats and misses
Who reports nextBeat on EPS
- FCNCAFY2026 Q3 · October 23, 2026+19.9% EPS+8.2% move
- FCNCNFY2026 Q3 · October 23, 2026+19.9% EPS+0.2% move
- FCNCOFY2026 Q3 · October 23, 2026+19.9% EPS+1.0% move
- FCNCPFY2026 Q3 · October 23, 2026+19.9% EPS+1.0% move
- RDYFY2027 Q2 · October 23, 2026+24.0% EPS-0.2% move
- SLBFY2026 Q3 · October 23, 2026+3.7% EPS+7.1% move
Missed on EPS
- INFYFY2027 Q2 · October 23, 2026-4.8% EPS-6.6% move
- BBDFY2026 Q3 · October 22, 2026-7.7% EPS+3.0% move
- SNAFY2026 Q3 · October 22, 2026-5.9% EPS-3.4% move
- SPOTFY2026 Q3 · October 22, 2026-11.6% EPS+11.1% move
- VRSNFY2026 Q3 · October 22, 2026-2.0% EPS-0.9% move
- HBANMFY2026 Q3 · October 22, 2026-5.3% EPS+0.5% move
Get the BBY recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2024-11-11T06:39:45.180704+00:00
- Polygon adjusted daily market bars · 2026-10-25T07:00:43.038189+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-25T07:00:43.035364+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-25. For educational purposes only; not investment advice.